Saturday November 21 2009 | Biotechnology feed | All feeds
|
|
Xgene Corporation
Download detailed PDF Members: Xgene Corporation was founded in 1998 by Dr. Hoeffler just as he was leaving Stanford University Medical School's Department of Dermatology. The company was created to commercialize technology developed for producing a full-thickness human skin equivalent, CeSSETM (Cell-Sorted Skin Equivalent), pronounced "cease." This acronym has special meaning in light of worldwide legislation mandating the cessation of animal testing. Xgene's skin model based on the CeSSETM technology is called AccuskinTM and has immediate application as a substitute for animal testing, and so Xgene is uniquely positioned to take advantage of a lucrative new market. AccuskinTM has broad applications in the cosmetics, personal care, and other consumer products industries and therefore there is an immediate need for human skin for testing and future grafting. This, in combination with medical application in wound healing and disease, has created tremendous demand for our products and services. The patent position for the CeSSETM technology, as well as multiple patents pending on enhancements of this technology, is owned by Xgene Corporation worldwide.
This page has been viewed 940 times since April 2007, the link to the organisation's website has been followed 162 times Recent Search Terms used to find this page: xgene corporation | xgene | xgene | xgene co | xgene corporation | biotech corporation,SAN FRANCISCO | xgene stanford | xgene | Xgene Corporation founded | . Search for more companies in Saulsalito Search for more companies in California This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Xgene Corporation | ||||||||||||||||||||||||||||||||||
|